Skip to main content
Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery 2/2022

07.11.2020 | Original Article

Comparison of Diagnostic Reliability of p63 and Smooth Muscle Actin in Salivary Gland Neoplasms

verfasst von: E. Aswani, Herald J. Sherlin, Gifrina Jayaraj, K. R. Don, Archana Santhanam

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Sonderheft 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Salivary gland neoplasms pose considerable diagnostic difficulty owing to their diverse histological features in individual lesions and the presence of a number of types and variants & similar histological features with other tumor entities. Myoepithelial and basal cells play a significant role in the pathogenesis of salivary gland neoplasm. p63 and smooth muscle actin are more reliable markers for identifying these cells and not studied much comparing their reliability in the diagnosis of salivary gland neoplasms. Hence, the aim of this study is to evaluate and compare the diagnostic reliability of immunohistochemical markers such as p63 and smooth muscle actin (SMA) in the diagnosis of various benign and malignant salivary gland neoplasms. The study comprises of 18 samples categorized into two groups: Group I comprised 9 cases, of which 4 cases were Pleomorphic adenoma, 2 cases were Myoepithelioma, 2 cases of Basal cell adenoma and 1 case was Warthin's tumor; and Group II consisted of 9cases, of which 3 was Mucoepidermoid carcinoma, 1 cases were Myoepithelial carcinoma and 5 cases were Adenoid cystic carcinoma. The selected cases were subjected to immunohistochemistry (IHC) procedure to assess the expression pattern of p63 and smooth muscle actin. The obtained data was analysed statistically by using Mann–Whitney test. In SMA, strong positivity for epithelial and connective tissue components of benign salivary neoplasm is about 22.2%respectively. In malignant salivary neoplasm, SMA was strongly positive for the epithelial and connective tissue component of about 77.7% and 88.8% cases respectively. The difference in the connective tissue components was found to be statistically significant (U = 24, P = 0.032). P63 was strongly positive for the epithelial and connective tissue component of benign salivary neoplasm of about 33.3% and 11.1% cases respectively.In malignant salivary neoplasm, p63 was strongly positive for the epithelial component of about 66.6% cases and connective tissue is completely negative. Alpha-SMA can be utilized as reliable IHC markers for salivary gland neoplasms due to its diagnostic importance in tumors with myoepithelial origin indicative of the histogenesis of salivary gland tumors and even p63 can be used as specific markers for differentiation of malignant salivary gland tumors.
Literatur
1.
2.
Zurück zum Zitat Zhu S, Schuerch C, Hunt J (2015) Review and updates of immunohistochemistry in selected salivary gland and head and neck tumors. Arch Pathol Lab Med 139(1):55–66CrossRefPubMed Zhu S, Schuerch C, Hunt J (2015) Review and updates of immunohistochemistry in selected salivary gland and head and neck tumors. Arch Pathol Lab Med 139(1):55–66CrossRefPubMed
3.
Zurück zum Zitat Simpson RH (1994) Classification of tumours of the salivary glands. Histopathology 24(2):187–191CrossRefPubMed Simpson RH (1994) Classification of tumours of the salivary glands. Histopathology 24(2):187–191CrossRefPubMed
4.
Zurück zum Zitat Speight PM, Barrett AW (2009) Prognostic factors in malignant tumours of the salivary glands. Br J Oral Maxillofac Surg 47(8):587–593CrossRefPubMed Speight PM, Barrett AW (2009) Prognostic factors in malignant tumours of the salivary glands. Br J Oral Maxillofac Surg 47(8):587–593CrossRefPubMed
5.
Zurück zum Zitat Kumaran JV, Daniel MJ, Krishnan M, Selvam S (2019) Salivary gland tumors: an institutional experience. SRM J Res Dental Sci 10(1):12CrossRef Kumaran JV, Daniel MJ, Krishnan M, Selvam S (2019) Salivary gland tumors: an institutional experience. SRM J Res Dental Sci 10(1):12CrossRef
7.
Zurück zum Zitat World Health Organization, International Agency for Research on Cancer (2005) Pathology and genetics of head and neck tumours, IARC, France, p 430 World Health Organization, International Agency for Research on Cancer (2005) Pathology and genetics of head and neck tumours, IARC, France, p 430
8.
Zurück zum Zitat Nagao T, Sato E, Inoue R, Oshiro H, Takahashi H, Nagai T, et al (2012) Immunohistochemical analysis of salivary gland tumors: application for surgical pathology practice. Acta Histochem Cytochem 45(5):269–282CrossRefPubMedPubMedCentral Nagao T, Sato E, Inoue R, Oshiro H, Takahashi H, Nagai T, et al (2012) Immunohistochemical analysis of salivary gland tumors: application for surgical pathology practice. Acta Histochem Cytochem 45(5):269–282CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Ravi M, Boaz K, Natarajan S, Lewis A, Prasad M, Yellapurkar S (2018) Expression of α-smooth muscle actin in benign and malignant salivary gland tumors: an immunohistochemical study. Indian J Pathol Microbiol 61(4):479–484CrossRefPubMed Ravi M, Boaz K, Natarajan S, Lewis A, Prasad M, Yellapurkar S (2018) Expression of α-smooth muscle actin in benign and malignant salivary gland tumors: an immunohistochemical study. Indian J Pathol Microbiol 61(4):479–484CrossRefPubMed
10.
Zurück zum Zitat Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398(6729):708–713CrossRefPubMed Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398(6729):708–713CrossRefPubMed
11.
Zurück zum Zitat Yang A, Kaghad M, Caput D, McKeon F (2002) On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet 18(2):90–95CrossRefPubMed Yang A, Kaghad M, Caput D, McKeon F (2002) On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet 18(2):90–95CrossRefPubMed
12.
Zurück zum Zitat Guo X, Keyes WM, Papazoglu C, Zuber J, Li W, Lowe SW et al (2009) TAp63 induces senescence and suppresses tumorigenesis in vivo. Nat Cell Biol 11(12):1451–1457CrossRefPubMedPubMedCentral Guo X, Keyes WM, Papazoglu C, Zuber J, Li W, Lowe SW et al (2009) TAp63 induces senescence and suppresses tumorigenesis in vivo. Nat Cell Biol 11(12):1451–1457CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Bilal H, Handra-Luca A, Bertrand J-C, Fouret PJ (2003) P63 is expressed in basal and myoepithelial cells of human normal and tumor salivary gland tissues. J Histochem Cytochem 51(2):133–139CrossRefPubMed Bilal H, Handra-Luca A, Bertrand J-C, Fouret PJ (2003) P63 is expressed in basal and myoepithelial cells of human normal and tumor salivary gland tissues. J Histochem Cytochem 51(2):133–139CrossRefPubMed
14.
Zurück zum Zitat Weiler C, Reu S, Zengel P, Kirchner T, Ihrler S (2009) Obligate basal cell component in salivary oncocytoma facilitates distinction from acinic cell carcinoma. Pathol Res Pract 205(12):838–842CrossRefPubMed Weiler C, Reu S, Zengel P, Kirchner T, Ihrler S (2009) Obligate basal cell component in salivary oncocytoma facilitates distinction from acinic cell carcinoma. Pathol Res Pract 205(12):838–842CrossRefPubMed
15.
Zurück zum Zitat Etemad-Moghadam S, Khalili M (2009) Evaluation of myofibroblasts in oral epithelial dysplasia and squamous cell carcinoma. Journal of oral [Internet] 38(8):639–643 Etemad-Moghadam S, Khalili M (2009) Evaluation of myofibroblasts in oral epithelial dysplasia and squamous cell carcinoma. Journal of oral [Internet] 38(8):639–643
16.
Zurück zum Zitat Crivelini MM, de Sousa SO, de Araújo VC (1997) Immunohistochemical study of acinic cell carcinoma of minor salivary gland. Oral Oncol 33(3):204–208CrossRefPubMed Crivelini MM, de Sousa SO, de Araújo VC (1997) Immunohistochemical study of acinic cell carcinoma of minor salivary gland. Oral Oncol 33(3):204–208CrossRefPubMed
17.
Zurück zum Zitat Raman S, Sherlin HJ (2019) Utility of smooth muscle actin and CD117 as reliable markers in the diagnosis of salivary gland neoplasms. J Oral Maxillofac Pathol 23(2):218–223CrossRefPubMedPubMedCentral Raman S, Sherlin HJ (2019) Utility of smooth muscle actin and CD117 as reliable markers in the diagnosis of salivary gland neoplasms. J Oral Maxillofac Pathol 23(2):218–223CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Furuse C, de Sousa SOM, Nunes FD, de Magalhães MHCG, de Araújo VC (2005) Myoepithelial cell markers in salivary gland neoplasms. Int J Surg Pathol 13(1):57–65CrossRefPubMed Furuse C, de Sousa SOM, Nunes FD, de Magalhães MHCG, de Araújo VC (2005) Myoepithelial cell markers in salivary gland neoplasms. Int J Surg Pathol 13(1):57–65CrossRefPubMed
19.
Zurück zum Zitat Savera AT, Zarbo RJ (2004) Defining the role of myoepithelium in salivary gland neoplasia. Adv Anat Pathol 11(2):69–85CrossRefPubMed Savera AT, Zarbo RJ (2004) Defining the role of myoepithelium in salivary gland neoplasia. Adv Anat Pathol 11(2):69–85CrossRefPubMed
20.
Zurück zum Zitat Ogawa Y (2003) Immunocytochemistry of myoepithelial cells in the salivary glands. Prog Histochem Cytochem 38(4):343–426CrossRefPubMed Ogawa Y (2003) Immunocytochemistry of myoepithelial cells in the salivary glands. Prog Histochem Cytochem 38(4):343–426CrossRefPubMed
21.
Zurück zum Zitat Hirano T, Gluckman JL, deVries EJ (1990) The expression of alpha vascular smooth-muscle actin in salivary gland tumors. Arch Otolaryngol Head Neck Surg 116(6):692–696CrossRefPubMed Hirano T, Gluckman JL, deVries EJ (1990) The expression of alpha vascular smooth-muscle actin in salivary gland tumors. Arch Otolaryngol Head Neck Surg 116(6):692–696CrossRefPubMed
22.
Zurück zum Zitat Dardick I, Daya D, Hardie J, van Nostrand AW (1984) Mucoepidermoid carcinoma: ultrastructural and histogenetic aspects. J Oral Pathol 13(4):342–358CrossRefPubMed Dardick I, Daya D, Hardie J, van Nostrand AW (1984) Mucoepidermoid carcinoma: ultrastructural and histogenetic aspects. J Oral Pathol 13(4):342–358CrossRefPubMed
23.
Zurück zum Zitat Sharma S, Evans A, Hemers E (2016) Mesenchymal-epithelial signalling in tumour microenvironment: role of high-mobility group Box 1. Cell Tissue Res 365(2):357–366CrossRefPubMedPubMedCentral Sharma S, Evans A, Hemers E (2016) Mesenchymal-epithelial signalling in tumour microenvironment: role of high-mobility group Box 1. Cell Tissue Res 365(2):357–366CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Teixeira LN, Janner ÉC, Teixeira T, Passador-Santos F, Martinez EF, Demasi APD et al (2019) Comparison of p63/p40 expression with myoepithelial markers in minor salivary gland tumors. Int J Surg Pathol 27(4):360–371CrossRefPubMed Teixeira LN, Janner ÉC, Teixeira T, Passador-Santos F, Martinez EF, Demasi APD et al (2019) Comparison of p63/p40 expression with myoepithelial markers in minor salivary gland tumors. Int J Surg Pathol 27(4):360–371CrossRefPubMed
25.
Zurück zum Zitat Edwards PC, Bhuiya T, Kelsch RD (2004) Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97(5):613–619CrossRefPubMed Edwards PC, Bhuiya T, Kelsch RD (2004) Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97(5):613–619CrossRefPubMed
26.
Zurück zum Zitat Seethala RR, LiVolsi VA, Zhang PJ, Pasha TL, Baloch ZW (2005) Comparison of p63 and p73 expression in benign and malignant salivary gland lesions. Head Neck 27(8):696–702CrossRefPubMed Seethala RR, LiVolsi VA, Zhang PJ, Pasha TL, Baloch ZW (2005) Comparison of p63 and p73 expression in benign and malignant salivary gland lesions. Head Neck 27(8):696–702CrossRefPubMed
27.
Zurück zum Zitat McHugh JB, Hoschar AP, Dvorakova M, Parwani AV, Barnes EL, Seethala RR (2007) p63 immunohistochemistry differentiates salivary gland oncocytoma and oncocytic carcinoma from metastatic renal cell carcinoma. Head Neck Pathol 1(2):123–131CrossRefPubMedPubMedCentral McHugh JB, Hoschar AP, Dvorakova M, Parwani AV, Barnes EL, Seethala RR (2007) p63 immunohistochemistry differentiates salivary gland oncocytoma and oncocytic carcinoma from metastatic renal cell carcinoma. Head Neck Pathol 1(2):123–131CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Weinreb I, Seethala RR, Perez-Ordoñez B, Chetty R, Hoschar AP, Hunt JL (2009) Oncocytic mucoepidermoid carcinoma: clinicopathologic description in a series of 12 cases. Am J Surg Pathol 33(3):409–416CrossRefPubMed Weinreb I, Seethala RR, Perez-Ordoñez B, Chetty R, Hoschar AP, Hunt JL (2009) Oncocytic mucoepidermoid carcinoma: clinicopathologic description in a series of 12 cases. Am J Surg Pathol 33(3):409–416CrossRefPubMed
29.
Zurück zum Zitat Sams RN, Gnepp DR (2013) P63 expression can be used in differential diagnosis of salivary gland acinic cell and mucoepidermoid carcinomas. Head Neck Pathol 7(1):64–68CrossRefPubMed Sams RN, Gnepp DR (2013) P63 expression can be used in differential diagnosis of salivary gland acinic cell and mucoepidermoid carcinomas. Head Neck Pathol 7(1):64–68CrossRefPubMed
Metadaten
Titel
Comparison of Diagnostic Reliability of p63 and Smooth Muscle Actin in Salivary Gland Neoplasms
verfasst von
E. Aswani
Herald J. Sherlin
Gifrina Jayaraj
K. R. Don
Archana Santhanam
Publikationsdatum
07.11.2020
Verlag
Springer India
Erschienen in
Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe Sonderheft 2/2022
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-020-02237-6

Weitere Artikel der Sonderheft 2/2022

Indian Journal of Otolaryngology and Head & Neck Surgery 2/2022 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.